Patent · US Active

Small molecule inhibitors of Interleukin-4

US12043621B2 · kind B2 · utility

0Cited by
9References
27Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 19, 2021
Grant dateJul 23, 2024
Priority date
Expiry dateMar 19, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K16/2866
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The technology described herein is directed to IL-4 and/or IL-13 inhibitors and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.